Search Results 1511-1520 of 19965 for Receptor

  1. Prostate Cancer Clinical Trials - Mayo Clinic Research

    The goal of this clinical study is to determine the safety and efficacy of VT-464, a lyase-selective inhibitor of CYP17 and an androgen receptor antagonist ...

  2. Movement disorders - Doctors and departments - Mayo Clinic

    ... receptor antibody encephalitis. Show more areas of focus for Andrew McKeon, M.B., B.Ch., M.D.. Kai J. Miller, M.D., Ph.D ...

  3. A Study to Evaluate the Effectiveness of Antihistamines in the Treatment of Eosinophilic Esophagitis - Mayo Clinic

    Patients who have been treated with acid-suppressing medications (PPI or H2 receptor antagonists) in the previous 6 weeks. Patients on immunosuppressive or ...

  4. Relapsed or High-Risk Myeloma Receiving Novel Immunotherapies Outcomes of Patients - Mayo Clinic

    Participation eligibility · BCMA targeted cellular therapy including chimeric antigen receptor Tcells (CAR T-cells).; · BCMA targeted antibody-drug conjugate ...

  5. Atenolol for the Prevention of Osteoporosis (APO) - Mayo Clinic

    or treatment with a selective estrogen receptor modulator, or teriparatide/abaloparatide (within the past year) - Current use of digitalis glycosides

  6. Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy - Mayo Clinic

    ... receptor (FLT3) mutated Acute Myeloid Leukemia (AML) who are eligible for standard induction and consolidation chemotherapy. Participation eligibility.

  7. Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia - Mayo Clinic

    Positive promyelocytic leukemia/retinoic acid receptor PML/RAR alpha by polymerase chain reaction (PCR). Patients must accept treatment and supportive care ...

  8. Medical Research & Education - Mayo Clinic News Network

    ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...

  9. Medical Research & Education - Mayo Clinic News Network

    ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...

  10. Medical Research & Education - Mayo Clinic News Network

    Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to ...